Incassia 28 Day Shortage: What Providers and Prescribers Need to Know in 2026

Patients taking norethindrone 0.35 mg (Incassia 28 Day) have increasingly reported difficulty finding their prescription in stock at retail pharmacies. While the FDA's official drug shortage database does not list Incassia as of 2026, clinicians should be aware of the localized supply chain issues affecting this and related norethindrone brands — and should have a clear plan for counseling patients and managing substitutions.

Current Shortage Status (As of 2026)

Incassia 28 Day (norethindrone tablets USP 0.35 mg, manufactured by Aurobindo Pharma, NDC 65862-925) is not currently on the FDA Drug Shortages Database. However, patient-reported availability issues and pharmacy-level stock gaps are real and ongoing. The distinction matters clinically: while an official shortage would trigger formal FDA notification protocols, the current situation reflects regional supply chain variability — pharmacies stocking different norethindrone brands at different times.

Why Generic Norethindrone Availability Is Inconsistent

Norethindrone 0.35 mg is marketed under more than 10 brand names by multiple manufacturers. Pharmacies typically stock only 1–2 brands at a time based on their preferred wholesaler contracts. When one manufacturer experiences a production delay or a pharmacy's preferred brand is backordered, patients may find their specific brand unavailable even when the molecule is broadly available.

Additional pressures on norethindrone supply:

Post-2022 surge in demand for progestin-only contraceptives, as patients and providers sought estrogen-free options.

Telehealth prescribing expansion driving volume increases across all norethindrone brands.

API (active pharmaceutical ingredient) sourcing variability for Indian-manufactured generics.

Therapeutic Substitution: What Is Clinically Appropriate?

When Incassia is unavailable, the following substitution hierarchy is clinically reasonable:

Tier 1: Norethindrone 0.35 mg Generic Equivalents (No New Rx Needed in Most States)

All of the following are FDA-approved bioequivalent generics of norethindrone 0.35 mg. Pharmacist substitution is permitted in most states without a new prescription:

Camila 28 Day (Mayne Pharma)

Errin 28 Day (Barr Pharmaceuticals)

Heather 28 Day (Glenmark Pharmaceuticals)

Jencycla, Nora-Be, Sharobel, Lyza, Lyleq, Deblitane, Jolivette

Clinical note: These brands are FDA-rated AB-equivalent, meaning they have demonstrated bioequivalence to each other. Patients can switch between them without dosage adjustment or a therapeutic restart.

Tier 2: Drospirenone 4 mg (Slynd) — Requires New Rx

Slynd (drospirenone 4 mg) is a progestin-only pill that is pharmacologically distinct from norethindrone but appropriate as a therapeutic alternative for patients who need an estrogen-free contraceptive. Key clinical differences:

Ovulation suppression: >95% of cycles (vs ~50% for norethindrone)

Missed-pill window: 24 hours (vs 3 hours for norethindrone)

Antimineralocorticoid / anti-androgenic activity: may benefit patients with acne, PCOS, or fluid retention

Caution: Hyperkalemia risk in patients with renal impairment or those on potassium-sparing medications (ACE inhibitors, ARBs, NSAIDs)

Cost: Significantly higher without insurance (~$150–$200/month vs ~$18–$25 for norethindrone generics)

Tier 3: Long-Acting Progestin-Only Methods

For patients who experience persistent difficulty obtaining oral norethindrone, long-acting alternatives eliminate the daily pharmacy dependency:

Nexplanon (etonogestrel 68 mg implant): 3-year subdermal implant; >99% effective; appropriate for patients who cannot use estrogen.

Levonorgestrel IUD (Mirena, Kyleena, Liletta, Skyla): 3–8 years; >99% effective; estrogen-free.

Depo-Provera (medroxyprogesterone 150 mg IM q3 months): Effective; no daily adherence required. Delay in return of fertility of 3–10 months after discontinuation.

Counseling Points for Patients Experiencing Supply Disruptions

Emphasize the 3-hour missed-dose window. Patients must take norethindrone within 3 hours of their scheduled time, or use backup contraception for 48 hours.

Do not stop taking the pill while searching for more — use backup contraception and take any available dose rather than skip.

Coach patients to request the generic by name (norethindrone 0.35 mg) and accept any brand. Many patients don't realize they're brand-loyal to an interchangeable generic.

Consider prescribing a 90-day supply to reduce the frequency of supply disruptions for established patients.

How medfinder Supports Your Patients

medfinder is a service that calls pharmacies near your patients to identify which ones can fill their prescription. Providers can direct patients to medfinder.com/providers to learn more about how the service can support medication access for their patient population.

Related: How to Help Your Patients Find Incassia 28 Day In Stock: A Provider's Guide.